Total: £ 56.28
Published Date: 2025-08-07 | Pages: 97 | Tables: 92 | Medical Care
The global Pathological Examination market size was US$ 34133 million in 2024 and is forecast to a readjusted size of US$ 65912 million by 2031 with a CAGR of 10.0% during the forecast period 2025-2031.
Pathological examination is a medical diagnostic process that involves the analysis of tissues, cells, or bodily fluids to determine the nature, cause, and extent of disease. It includes techniques such as histopathology, cytology, immunohistochemistry, and molecular pathology. As the gold standard for diagnosing cancers and many other diseases, pathological examination plays a critical role in clinical decision-making, surgical planning, and prognosis assessment.
The pathological examination market is driven by the increasing global incidence of cancer and other chronic diseases that require tissue-based diagnosis. As healthcare systems shift toward precision medicine, the demand for accurate, early-stage diagnostic tools such as histopathology, cytology, and molecular pathology continues to rise. Technological advancements—such as digital pathology, immunohistochemistry (IHC), and next-generation sequencing (NGS)—have expanded the scope of pathology beyond traditional microscopy, improving workflow efficiency, diagnostic accuracy, and enabling personalized treatment strategies.
Despite strong growth potential, the pathological examination market faces key challenges including a shortage of trained pathologists, especially in developing countries. Manual workflow in traditional pathology can be time-consuming and error-prone, and digital pathology implementation requires significant infrastructure investment, standardization, and regulatory approval. Furthermore, variability in tissue sample quality, complex reimbursement environments, and integration issues with hospital information systems (HIS/LIS) continue to pose barriers to the widespread adoption of advanced pathology technologies.
The global Pathological Examination market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Quest Diagnostics
Sonic Healthcare
Lab Corp
Unilabs
SYNLAB International
BML
Pathologists Diagnostic
StageBio
KingMed Diagnostics Group
Dian Diagnostics Group
Adicon Clinical Laboratories Inc.
Huayin Health
By Type: (Dominant Segment vs High-Margin Innovation)
Histopathology
Cytopathology
Immunohistochemical Pathology
Molecular Pathology
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Medical Laboratory
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Quest Diagnostics in Europe)
- Emerging Product Trends: Histopathology adoption vs. Cytopathology premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Medical Laboratory potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Australia
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pathological Examination market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Cytopathology in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Medical Laboratory in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pathological Examination value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Histopathology
1.2.3 Cytopathology
1.2.4 Immunohistochemical Pathology
1.2.5 Molecular Pathology
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pathological Examination Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Pathological Examination Revenue Market Share by Region (2020-2025)
2.4 Global Pathological Examination Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Pathological Examination Market Size and Prospective (2020-2031)
2.5.2 Europe Pathological Examination Market Size and Prospective (2020-2031)
2.5.3 China Pathological Examination Market Size and Prospective (2020-2031)
2.5.4 Japan Pathological Examination Market Size and Prospective (2020-2031)
2.5.5 Australia Pathological Examination Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Pathological Examination Historic Market Size by Type (2020-2025)
3.2 Global Pathological Examination Forecasted Market Size by Type (2026-2031)
3.3 Different Types Pathological Examination Representative Players
4 Breakdown Data by Application
4.1 Global Pathological Examination Historic Market Size by Application (2020-2025)
4.2 Global Pathological Examination Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Pathological Examination Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Pathological Examination Players by Revenue (2020-2025)
5.1.2 Global Pathological Examination Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Pathological Examination Revenue
5.4 Global Pathological Examination Market Concentration Analysis
5.4.1 Global Pathological Examination Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Pathological Examination Revenue in 2024
5.5 Global Key Players of Pathological Examination Head office and Area Served
5.6 Global Key Players of Pathological Examination, Product and Application
5.7 Global Key Players of Pathological Examination, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Pathological Examination Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Pathological Examination Market Size by Type (2020-2025)
6.1.2.2 North America Pathological Examination Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Pathological Examination Market Size by Application (2020-2025)
6.1.3.2 North America Pathological Examination Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Pathological Examination Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Pathological Examination Market Size by Type (2020-2025)
6.2.2.2 Europe Pathological Examination Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Pathological Examination Market Size by Application (2020-2025)
6.2.3.2 Europe Pathological Examination Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Pathological Examination Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Pathological Examination Market Size by Type (2020-2025)
6.3.2.2 China Pathological Examination Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Pathological Examination Market Size by Application (2020-2025)
6.3.3.2 China Pathological Examination Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Pathological Examination Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Pathological Examination Market Size by Type (2020-2025)
6.4.2.2 Japan Pathological Examination Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Pathological Examination Market Size by Application (2020-2025)
6.4.3.2 Japan Pathological Examination Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Australia Market: Players, Segments and Downstream
6.5.1 Australia Pathological Examination Revenue by Company (2020-2025)
6.5.2 Australia Market Size by Type
6.5.2.1 Australia Pathological Examination Market Size by Type (2020-2025)
6.5.2.2 Australia Pathological Examination Market Share by Type (2020-2025)
6.5.3 Australia Market Size by Application
6.5.3.1 Australia Pathological Examination Market Size by Application (2020-2025)
6.5.3.2 Australia Pathological Examination Market Share by Application (2020-2025)
6.5.4 Australia Market Trend and Opportunities
7 Key Players Profiles
7.1 Quest Diagnostics
7.1.1 Quest Diagnostics Company Details
7.1.2 Quest Diagnostics Business Overview
7.1.3 Quest Diagnostics Pathological Examination Introduction
7.1.4 Quest Diagnostics Revenue in Pathological Examination Business (2020-2025)
7.1.5 Quest Diagnostics Recent Development
7.2 Sonic Healthcare
7.2.1 Sonic Healthcare Company Details
7.2.2 Sonic Healthcare Business Overview
7.2.3 Sonic Healthcare Pathological Examination Introduction
7.2.4 Sonic Healthcare Revenue in Pathological Examination Business (2020-2025)
7.2.5 Sonic Healthcare Recent Development
7.3 Lab Corp
7.3.1 Lab Corp Company Details
7.3.2 Lab Corp Business Overview
7.3.3 Lab Corp Pathological Examination Introduction
7.3.4 Lab Corp Revenue in Pathological Examination Business (2020-2025)
7.3.5 Lab Corp Recent Development
7.4 Unilabs
7.4.1 Unilabs Company Details
7.4.2 Unilabs Business Overview
7.4.3 Unilabs Pathological Examination Introduction
7.4.4 Unilabs Revenue in Pathological Examination Business (2020-2025)
7.4.5 Unilabs Recent Development
7.5 SYNLAB International
7.5.1 SYNLAB International Company Details
7.5.2 SYNLAB International Business Overview
7.5.3 SYNLAB International Pathological Examination Introduction
7.5.4 SYNLAB International Revenue in Pathological Examination Business (2020-2025)
7.5.5 SYNLAB International Recent Development
7.6 BML
7.6.1 BML Company Details
7.6.2 BML Business Overview
7.6.3 BML Pathological Examination Introduction
7.6.4 BML Revenue in Pathological Examination Business (2020-2025)
7.6.5 BML Recent Development
7.7 Pathologists Diagnostic
7.7.1 Pathologists Diagnostic Company Details
7.7.2 Pathologists Diagnostic Business Overview
7.7.3 Pathologists Diagnostic Pathological Examination Introduction
7.7.4 Pathologists Diagnostic Revenue in Pathological Examination Business (2020-2025)
7.7.5 Pathologists Diagnostic Recent Development
7.8 StageBio
7.8.1 StageBio Company Details
7.8.2 StageBio Business Overview
7.8.3 StageBio Pathological Examination Introduction
7.8.4 StageBio Revenue in Pathological Examination Business (2020-2025)
7.8.5 StageBio Recent Development
7.9 KingMed Diagnostics Group
7.9.1 KingMed Diagnostics Group Company Details
7.9.2 KingMed Diagnostics Group Business Overview
7.9.3 KingMed Diagnostics Group Pathological Examination Introduction
7.9.4 KingMed Diagnostics Group Revenue in Pathological Examination Business (2020-2025)
7.9.5 KingMed Diagnostics Group Recent Development
7.10 Dian Diagnostics Group
7.10.1 Dian Diagnostics Group Company Details
7.10.2 Dian Diagnostics Group Business Overview
7.10.3 Dian Diagnostics Group Pathological Examination Introduction
7.10.4 Dian Diagnostics Group Revenue in Pathological Examination Business (2020-2025)
7.10.5 Dian Diagnostics Group Recent Development
7.11 Adicon Clinical Laboratories Inc.
7.11.1 Adicon Clinical Laboratories Inc. Company Details
7.11.2 Adicon Clinical Laboratories Inc. Business Overview
7.11.3 Adicon Clinical Laboratories Inc. Pathological Examination Introduction
7.11.4 Adicon Clinical Laboratories Inc. Revenue in Pathological Examination Business (2020-2025)
7.11.5 Adicon Clinical Laboratories Inc. Recent Development
7.12 Huayin Health
7.12.1 Huayin Health Company Details
7.12.2 Huayin Health Business Overview
7.12.3 Huayin Health Pathological Examination Introduction
7.12.4 Huayin Health Revenue in Pathological Examination Business (2020-2025)
7.12.5 Huayin Health Recent Development
8 Pathological Examination Market Dynamics
8.1 Pathological Examination Industry Trends
8.2 Pathological Examination Market Drivers
8.3 Pathological Examination Market Challenges
8.4 Pathological Examination Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Pathological Examination Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Pathological Examination Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Pathological Examination Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Pathological Examination Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Pathological Examination Revenue Share by Region (2020-2025)
Table 6. Global Pathological Examination Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Pathological Examination Revenue Share Forecast by Region (2026-2031)
Table 8. Global Pathological Examination Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Pathological Examination Revenue Market Share by Type (2020-2025)
Table 10. Global Pathological Examination Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Pathological Examination Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Pathological Examination Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Pathological Examination Revenue Market Share by Application (2020-2025)
Table 15. Global Pathological Examination Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Pathological Examination Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Pathological Examination Application
Table 18. Global Pathological Examination Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Pathological Examination Market Share by Players (2020-2025)
Table 20. Global Top Pathological Examination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathological Examination as of 2024)
Table 21. Ranking of Global Top Pathological Examination Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Pathological Examination Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Pathological Examination, Headquarters and Area Served
Table 24. Global Key Players of Pathological Examination, Product and Application
Table 25. Global Key Players of Pathological Examination, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Pathological Examination Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Pathological Examination Revenue Market Share by Company (2020-2025)
Table 29. North America Pathological Examination Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Pathological Examination Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Pathological Examination Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Pathological Examination Revenue Market Share by Company (2020-2025)
Table 33. Europe Pathological Examination Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Pathological Examination Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Pathological Examination Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Pathological Examination Revenue Market Share by Company (2020-2025)
Table 37. China Pathological Examination Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Pathological Examination Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Pathological Examination Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Pathological Examination Revenue Market Share by Company (2020-2025)
Table 41. Japan Pathological Examination Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Pathological Examination Market Size by Application (2020-2025) & (US$ Million)
Table 43. Australia Pathological Examination Revenue by Company (2020-2025) & (US$ Million)
Table 44. Australia Pathological Examination Revenue Market Share by Company (2020-2025)
Table 45. Australia Pathological Examination Market Size by Type (2020-2025) & (US$ Million)
Table 46. Australia Pathological Examination Market Size by Application (2020-2025) & (US$ Million)
Table 47. Quest Diagnostics Company Details
Table 48. Quest Diagnostics Business Overview
Table 49. Quest Diagnostics Pathological Examination Product
Table 50. Quest Diagnostics Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 51. Quest Diagnostics Recent Development
Table 52. Sonic Healthcare Company Details
Table 53. Sonic Healthcare Business Overview
Table 54. Sonic Healthcare Pathological Examination Product
Table 55. Sonic Healthcare Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 56. Sonic Healthcare Recent Development
Table 57. Lab Corp Company Details
Table 58. Lab Corp Business Overview
Table 59. Lab Corp Pathological Examination Product
Table 60. Lab Corp Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 61. Lab Corp Recent Development
Table 62. Unilabs Company Details
Table 63. Unilabs Business Overview
Table 64. Unilabs Pathological Examination Product
Table 65. Unilabs Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 66. Unilabs Recent Development
Table 67. SYNLAB International Company Details
Table 68. SYNLAB International Business Overview
Table 69. SYNLAB International Pathological Examination Product
Table 70. SYNLAB International Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 71. SYNLAB International Recent Development
Table 72. BML Company Details
Table 73. BML Business Overview
Table 74. BML Pathological Examination Product
Table 75. BML Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 76. BML Recent Development
Table 77. Pathologists Diagnostic Company Details
Table 78. Pathologists Diagnostic Business Overview
Table 79. Pathologists Diagnostic Pathological Examination Product
Table 80. Pathologists Diagnostic Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 81. Pathologists Diagnostic Recent Development
Table 82. StageBio Company Details
Table 83. StageBio Business Overview
Table 84. StageBio Pathological Examination Product
Table 85. StageBio Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 86. StageBio Recent Development
Table 87. KingMed Diagnostics Group Company Details
Table 88. KingMed Diagnostics Group Business Overview
Table 89. KingMed Diagnostics Group Pathological Examination Product
Table 90. KingMed Diagnostics Group Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 91. KingMed Diagnostics Group Recent Development
Table 92. Dian Diagnostics Group Company Details
Table 93. Dian Diagnostics Group Business Overview
Table 94. Dian Diagnostics Group Pathological Examination Product
Table 95. Dian Diagnostics Group Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 96. Dian Diagnostics Group Recent Development
Table 97. Adicon Clinical Laboratories Inc. Company Details
Table 98. Adicon Clinical Laboratories Inc. Business Overview
Table 99. Adicon Clinical Laboratories Inc. Pathological Examination Product
Table 100. Adicon Clinical Laboratories Inc. Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 101. Adicon Clinical Laboratories Inc. Recent Development
Table 102. Huayin Health Company Details
Table 103. Huayin Health Business Overview
Table 104. Huayin Health Pathological Examination Product
Table 105. Huayin Health Revenue in Pathological Examination Business (2020-2025) & (US$ Million)
Table 106. Huayin Health Recent Development
Table 107. Pathological Examination Market Trends
Table 108. Pathological Examination Market Drivers
Table 109. Pathological Examination Market Challenges
Table 110. Pathological Examination Market Restraints
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Pathological Examination Product Picture
Figure 2. Global Pathological Examination Market Share by Type: 2024 VS 2031
Figure 3. Histopathology Features
Figure 4. Cytopathology Features
Figure 5. Immunohistochemical Pathology Features
Figure 6. Molecular Pathology Features
Figure 7. Global Pathological Examination Market Share by Application: 2024 VS 2031
Figure 8. Hospital
Figure 9. Medical Laboratory
Figure 10. Pathological Examination Report Years Considered
Figure 11. Global Pathological Examination Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Pathological Examination Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Pathological Examination Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Pathological Examination Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Pathological Examination Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Pathological Examination Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Pathological Examination Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Australia Pathological Examination Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Pathological Examination Market Share by Players in 2024
Figure 20. Global Top Pathological Examination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathological Examination as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Pathological Examination Revenue in 2024
Figure 22. North America Pathological Examination Market Share by Type (2020-2025)
Figure 23. North America Pathological Examination Market Share by Application (2020-2025)
Figure 24. Europe Pathological Examination Market Share by Type (2020-2025)
Figure 25. Europe Pathological Examination Market Share by Application (2020-2025)
Figure 26. China Pathological Examination Market Share by Type (2020-2025)
Figure 27. China Pathological Examination Market Share by Application (2020-2025)
Figure 28. Japan Pathological Examination Market Share by Type (2020-2025)
Figure 29. Japan Pathological Examination Market Share by Application (2020-2025)
Figure 30. Australia Pathological Examination Market Share by Type (2020-2025)
Figure 31. Australia Pathological Examination Market Share by Application (2020-2025)
Figure 32. Quest Diagnostics Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 33. Sonic Healthcare Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 34. Lab Corp Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 35. Unilabs Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 36. SYNLAB International Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 37. BML Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 38. Pathologists Diagnostic Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 39. StageBio Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 40. KingMed Diagnostics Group Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 41. Dian Diagnostics Group Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 42. Adicon Clinical Laboratories Inc. Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 43. Huayin Health Revenue Growth Rate in Pathological Examination Business (2020-2025)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed